Multiplex Zymography Captures Stage-specific Activity Profiles of Cathepsins K, L, and S in Human Breast, Lung, and Cervical Cancer

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Chen, Binbin ^a   Platt, Manu O ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CATHEPSIN; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; MALE; MULTIPLEX ZYMOGRAPHY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; ZYMOGRAPHY; ANTIBODY SPECIFICITY; BREAST TUMOR; ENZYMOLOGY; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOPLASM; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REFERENCE VALUE; UTERINE CERVIX TUMOR;

ADULT; BREAST NEOPLASMS; CATHEPSINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; ORGAN SPECIFICITY; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 79960555690     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-109     Document Type: Article

References (41)

1. Gocheva V, Joyce JA. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 2007, 6:60-64. 10.4161/cc.6.1.3669, 17245112.
2. Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006, 6:764-775. 10.1038/nrc1949, 16990854.
3. Turk B, Turk D, Turk V. Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 2000, 1477:98-111. 10.1016/S0167-4838(99)00263-0, 10708852.
4. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, Emmert-Buck MR. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 1994, 145:301-309. 1887383, 7519824.
5. Jessup JM. Cathepsin B and other proteases in human colorectal carcinoma. Am J Pathol 1994, 145:253-262. 1887384, 8053486.
6. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997, 59:63-88. 10.1146/annurev.physiol.59.1.63, 9074757.
7. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaisse JM. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352. 10.1074/jbc.273.48.32347, 9822715.
8. Buhling F, Rocken C, Brasch F, Hartig R, Yasuda Y, Saftig P, Bromme D, Welte T. Pivotal role of cathepsin K in lung fibrosis. Am J Pathol 2004, 164:2203-2216. 10.1016/S0002-9440(10)63777-7, 1615770, 15161653.
9. Cheng XW, Kuzuya M, Sasaki T, Arakawa K, Kanda S, Sumi D, Koike T, Maeda K, Tamaya-Mori N, Shi GP, et al. Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries. Am J Pathol 2004, 164:243-251. 10.1016/S0002-9440(10)63114-8, 1602234, 14695337.
10. Lindeman JH, Hanemaaijer R, Mulder A, Dijkstra PD, Szuhai K, Bromme D, Verheijen JH, Hogendoorn PC. Cathepsin K is the principal protease in giant cell tumor of bone. Am J Pathol 2004, 165:593-600. 10.1016/S0002-9440(10)63323-8, 1618565, 15277232.
11. Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, Olive MB, Sloane BF. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol 2009, 175:1255-1269. 10.2353/ajpath.2009.080906, 2731144, 19700761.
12. Kim K, Cai J, Shuja S, Kuo T, Murnane MJ. Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas. Int J Cancer 1998, 79:324-333. 10.1002/(SICI)1097-0215(19980821)79:4<324::AID-IJC4>3.0.CO;2-X, 9699522.
13. Liu Y, Li X, Peng D, Tan Z, Liu H, Qing Y, Xue Y, Shi GP. Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease. Am J Cardiol 2009, 103:476-481. 10.1016/j.amjcard.2008.10.011, 2752663, 19195505.
14. Platt MO, Ankeny RF, Jo H. Laminar shear stress inhibits cathepsin L activity in endothelial cells. Arterioscler Thromb Vasc Biol 2006, 26:1784-1790. 10.1161/01.ATV.0000227470.72109.2b, 16709945.
15. Reddy VY, Zhang QY, Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 1995, 92:3849-3853. 10.1073/pnas.92.9.3849, 42059, 7731994.
16. Novinec M, Grass RN, Stark WJ, Turk V, Baici A, Lenarcic B. Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors. J Biol Chem 2007, 282:7893-7902. 10.1074/jbc.M610107200, 17227755.
17. Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y, Pan JH, Lu ML, Cheng XW, Iguchi A, et al. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 2003, 92:493-500. 10.1161/01.RES.0000060485.20318.96, 12600886.
18. Ward C, Kuehn D, Burden RE, Gormley JA, Jaquin TJ, Gazdoiu M, Small D, Bicknell R, Johnston JA, Scott CJ, Olwill SA. Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. PLoS One 2010, 5.
19. Le Gall C, Bonnelye E, Clezardin P. Cathepsin K inhibitors as treatment of bone metastasis. Curr Opin Support Palliat Care 2008, 2:218-222. 10.1097/SPC.0b013e32830baea9, 18685424.
20. Desmarais S, Masse F, Percival MD. Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools. Biol Chem 2009, 390:941-948. 10.1515/BC.2009.092, 19453281.
21. Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarski B, Kokubo T, Inaoka T, Sloane J, Evans DB, Gallagher JA. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 1997, 57:5386-5390.
22. Brubaker KD, Vessella RL, True LD, Thomas R, Corey E. Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Miner Res 2003, 18:222-230. 10.1359/jbmr.2003.18.2.222, 12568399.
23. Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, et al. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res 2008, 14:5357-5367. 10.1158/1078-0432.CCR-08-0732, 2630242, 18765527.
24. Greenbaum D, Baruch A, Hayrapetian L, Darula Z, Burlingame A, Medzihradszky KF, Bogyo M. Chemical approaches for functionally probing the proteome. Mol Cell Proteomics 2002, 1:60-68. 10.1074/mcp.T100003-MCP200, 12096141.
25. Barrett AJ, Kirschke H. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol 1981, 80:535-561.
26. Yasuda Y, Li Z, Greenbaum D, Bogyo M, Weber E, Bromme D. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J Biol Chem 2004, 279:36761-36770. 10.1074/jbc.M403986200, 15192101.
27. Li WA, Barry ZT, Cohen JD, Wilder CL, Deeds RJ, Keegan PM, Platt MO. Detection of femtomole quantities of mature cathepsin K with zymography. Anal Biochem 2010, 401:91-98. 10.1016/j.ab.2010.02.035, 20206119.
28. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010, 17:1471-1474. 10.1245/s10434-010-0985-4, 20180029.
29. Kurschat P, Wickenhauser C, Groth W, Krieg T, Mauch C. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. J Pathol 2002, 197:179-187. 10.1002/path.1080, 12015741.
30. Rasmussen HS, McCann PP. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 1997, 75:69-75. 10.1016/S0163-7258(97)00023-5, 9364582.
31. Chilosi M, Pea M, Martignoni G, Brunelli M, Gobbo S, Poletti V, Bonetti F. Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. Mod Pathol 2009, 22:161-166. 10.1038/modpathol.2008.189, 19060845.
32. Rapa I, Volante M, Cappia S, Rosas R, Scagliotti GV, Papotti M. Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. Am J Clin Pathol 2006, 125:847-854. 10.1309/Q96AYDAAJ3E1TNWT, 16690483.
33. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007, 7:11-22. 10.1038/nrc2050, 17186016.
34. Szabova L, Yamada SS, Wimer H, Chrysovergis K, Ingvarsen S, Behrendt N, Engelholm LH, Holmbeck K. MT1-MMP and type II collagen specify skeletal stem cells and their bone and cartilage progeny. J Bone Miner Res 2009, 24:1905-1916. 10.1359/jbmr.090510, 2765933, 19419317.
35. Platt MO, Ankeny RF, Shi GP, Weiss D, Vega JD, Taylor WR, Jo H. Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. Am J Physiol Heart Circ Physiol 2007, 292:H1479-1486.
36. Gocheva V, Wang HW, Gadea BB, Shree T, Hunter KE, Garfall AL, Berman T, Joyce JA. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24:241-255.
37. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A. Macrophage polarization in tumour progression. Semin Cancer Biol 2008, 18:349-355. 10.1016/j.semcancer.2008.03.004, 18467122.
38. Collette J, Ulku AS, Der CJ, Jones A, Erickson AH. Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells. Int J Cancer 2004, 112:190-199. 10.1002/ijc.20398, 15352030.
39. Chapman HA, Stone OL, Vavrin Z. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J Clin Invest 1984, 73:806-815. 10.1172/JCI111275, 425084, 6368589.
40. Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006, 20:543-556. 10.1101/gad.1407406, 1410800, 16481467.
41. Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, Sloane BF, Bogyo M. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 2005, 1:203-209. 10.1038/nchembio728, 16408036.